Brief Alcohol Intervention for Adolescents Who Have Attempted Suicide


The study will use a two group randomized controlled trial to compare a brief motivational interviewing (MI) intervention to TAU with 50 adolescents psychiatrically hospitalized for a suicide plan or attempt who have co-occurring alcohol use. Data will be collected via in-person interviews and self-administered questionnaires at baseline and 3 month follow-up assessments to explore outcome changes in negative alcohol expectancies, confidence in ability to handle situations where alcohol is present, likelihood of receiving alcohol treatment, frequency of alcohol use, and suicidal ideation, suicide planning, and suicide attempts for adolescents receiving the intervention relative to TAU.

Study Start Date

October 2014

Estimated Completion Date

December 2016


  • Behavioral: motivational enhancement therapy


  • Nursing: Mental Health
  • Psychiatry: Mood Disorders,Substance Abuse
  • Family Medicine: Psychiatry

MeSH Terms

  • Alcohol
  • Attempted
  • Drinking
  • Drinking

Study ID

Children's Hospital Boston -- A00013929



Trial ID


Study Type


Trial Phase

Phase 1

Enrollment Quota



Children's Hospital Boston

Inclusion Criteria

  • current hospitalization for suicide plan or attempt,
  • alcohol use in past month, indicated by selecting 1-6 on Question #1 of the Adolescent Drinking Questionnaire (ADQ) which is currently given to all patients to fill out upon admission to the inpatient psychiatric unit,
  • age 13-17, and 4) ability to communicate in English.

Exclusion Criteria

  • developmental delay, autism spectrum disorder, or psychosis, per chart review.




13 Years to 17 Years

Accepts Healthy Volunteers


Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Boston Childrens Hospital - Boston, Massachusetts 2.6 miles Kimberly OBrien 617-521-3912 None provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.